MedKoo Cat#: 317533 | Name: Cinolazepam
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cinolazepam is a benzodiazepine derivative drug. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as an hypnotic.

Chemical Structure

Cinolazepam
Cinolazepam
CAS#75696-02-5

Theoretical Analysis

MedKoo Cat#: 317533

Name: Cinolazepam

CAS#: 75696-02-5

Chemical Formula: C18H13ClFN3O2

Exact Mass: 357.0680

Molecular Weight: 357.77

Elemental Analysis: C, 60.43; H, 3.66; Cl, 9.91; F, 5.31; N, 11.75; O, 8.94

Price and Availability

Size Price Availability Quantity
1mg USD 350.00 2 Weeks
5mg USD 850.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Cinolazepam; Gerodorm; Cinolazepamum; OX-373; OX373; OX 373;
IUPAC/Chemical Name
3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile
InChi Key
XAXMYHMKTCNRRZ-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2
SMILES Code
C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCC#N)O)F
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 357.77 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Saletu B, Kindshofer G, Anderer P, Grünberger J. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise. Int J Clin Pharmacol Res. 1987;7(5):407-18. PubMed PMID: 2889679. 2: Oelschläger H, Volke J, Belal F. Analysis of drugs by polarography, XXXV: The polarographic behaviour of cinolazepam[1-(2-cyanoethyl)-7-chloro-3-hydroxy-5-(2-fluorophe n yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one] and assay of its tablets. Arch Pharm (Weinheim). 1992 Feb;325(2):65-8. PubMed PMID: 1605717. 3: Richards BL, Whittle SL, Buchbinder R. Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008922. doi: 10.1002/14651858.CD008922.pub2. Review. PubMed PMID: 22258993. 4: Walash MI, Belal F, Metwally ME, Hefnawy MM. A selective fluorimetric method for the determination of some 1,4-benzodiazepine drugs containing a hydroxyl group at C-3. J Pharm Biomed Anal. 1994 Nov;12(11):1417-23. PubMed PMID: 7849137. 5: Mascher H, Nitsche V, Schütz H. Separation, isolation and identification of optical isomers of 1,4-benzodiazepine glucuronides from biological fluids by reversed-phase high-performance liquid chromatography. J Chromatogr. 1984 Mar 9;306:231-9. PubMed PMID: 6715462.